Literature DB >> 30249744

Ascaris Larval Infection and Lung Invasion Directly Induce Severe Allergic Airway Disease in Mice.

Jill E Weatherhead1,2,3, Paul Porter2, Amy Coffey4, Dana Haydel4, Leroy Versteeg1, Bin Zhan1,3, Ana Clara Gazzinelli Guimarães5, Ricardo Fujiwara5, Ana M Jaramillo6, Maria Elena Bottazzi1,3,7,8, Peter J Hotez1,3,7,8, David B Corry9,4,10,11, Coreen M Beaumier1,7.   

Abstract

Ascaris lumbricoides (roundworm) is the most common helminth infection globally and a cause of lifelong morbidity that may include allergic airway disease, an asthma phenotype. We hypothesize that Ascaris larval migration through the lungs leads to persistent airway hyperresponsiveness (AHR) and type 2 inflammatory lung pathology despite resolution of infection that resembles allergic airway disease. Mice were infected with Ascaris by oral gavage. Lung AHR was measured by plethysmography and histopathology with hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) stains, and cytokine concentrations were measured by using Luminex Magpix. Ascaris-infected mice were compared to controls or mice with allergic airway disease induced by ovalbumin (OVA) sensitization and challenge (OVA/OVA). Ascaris-infected mice developed profound AHR starting at day 8 postinfection (p.i.), peaking at day 12 p.i. and persisting through day 21 p.i., despite resolution of infection, which was significantly increased compared to controls and OVA/OVA mice. Ascaris-infected mice had a robust type 2 cytokine response in both the bronchoalveolar lavage (BAL) fluid and lung tissue, similar to that of the OVA/OVA mice, including interleukin-4 (IL-4) (P < 0.01 and P < 0.01, respectively), IL-5 (P < 0.001 and P < 0.001), and IL-13 (P < 0.001 and P < 0.01), compared to controls. By histopathology, Ascaris-infected mice demonstrated early airway remodeling similar to, but more profound than, that in OVA/OVA mice. We found that Ascaris larval migration causes significant pulmonary damage, including AHR and type 2 inflammatory lung pathology that resembles an extreme form of allergic airway disease. Our findings indicate that ascariasis may be an important cause of allergic airway disease in regions of endemicity.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Ascariszzm321990; airway hyperreactivity; allergic airway disease; asthma; hygiene hypothesis

Mesh:

Substances:

Year:  2018        PMID: 30249744      PMCID: PMC6246907          DOI: 10.1128/IAI.00533-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Ascaris lumbricoides, Ascaris suum, or "Ascaris lumbrisuum"?

Authors:  Elizabeth Brito da Silva Alves; Maria José Conceição; Daniela Leles
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

Review 2.  Seasonal pneumonitis with eosinophilia. A study of larval ascariasis in Saudi Arabs.

Authors:  A P Gelpi; A Mustafa
Journal:  Am J Trop Med Hyg       Date:  1967-09       Impact factor: 2.345

3.  IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.

Authors:  Andrea Bree; Franklin J Schlerman; Michael Wadanoli; Lioudmila Tchistiakova; Kimberly Marquette; Xiang-Yang Tan; Bruce A Jacobson; Angela Widom; Timothy A Cook; Nancy Wood; Suresh Vunnum; Rustem Krykbaev; Xin Xu; Debra D Donaldson; Samuel J Goldman; Joseph Sypek; Marion T Kasaian
Journal:  J Allergy Clin Immunol       Date:  2007-03-26       Impact factor: 10.793

4.  Relationship between specific serum IgE to Ascaris lumbricoides and onset of respiratory symptoms in Bangladesh immigrants.

Authors:  G Di Lorenzo; M L Pacor; P Mansueto; M Esposito-Pellitteri; N Scichilone; V Ditta; C Lo Bianco; M S Leto-Barone; G Di Fede; R Corrocher; S Mansueto; G B Rini
Journal:  Int J Immunopathol Pharmacol       Date:  2006 Jul-Sep       Impact factor: 3.219

Review 5.  Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model.

Authors:  Sandra Bonne-Année; Jessica A Hess; David Abraham
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

6.  Co-infection with Ascaris lumbricoides modulates protective immune responses against Giardia duodenalis in school Venezuelan rural children.

Authors:  I Hagel; M Cabrera; F Puccio; C Santaella; E Buvat; B Infante; M Zabala; R Cordero; M C Di Prisco
Journal:  Acta Trop       Date:  2010-12-21       Impact factor: 3.112

7.  Toxocara infection and diminished lung function in a nationally representative sample from the United States population.

Authors:  Michael G Walsh
Journal:  Int J Parasitol       Date:  2010-11-09       Impact factor: 3.981

Review 8.  Worm Infections in Children.

Authors:  Jill E Weatherhead; Peter J Hotez
Journal:  Pediatr Rev       Date:  2015-08

9.  Essential role of Stat6 in IL-4 signalling.

Authors:  K Takeda; T Tanaka; W Shi; M Matsumoto; M Minami; S Kashiwamura; K Nakanishi; N Yoshida; T Kishimoto; S Akira
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

Review 10.  Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin.

Authors:  Judith E Allen; Tara E Sutherland
Journal:  Semin Immunol       Date:  2014-07-11       Impact factor: 11.130

View more
  15 in total

1.  A historical and systematic overview of Ascaris vaccine development.

Authors:  Ana Clara Gazzinelli-Guimarães; Pedro Gazzinelli-Guimarães; Jill E Weatherhead
Journal:  Parasitology       Date:  2021-08-09       Impact factor: 3.243

Review 2.  The yin and yang of human soil-transmitted helminth infections.

Authors:  Alex Loukas; Rick M Maizels; Peter J Hotez
Journal:  Int J Parasitol       Date:  2021-11-10       Impact factor: 4.330

Review 3.  Whipworm and roundworm infections.

Authors:  Kathryn J Else; Jennifer Keiser; Celia V Holland; Richard K Grencis; David B Sattelle; Ricardo T Fujiwara; Lilian L Bueno; Samuel O Asaolu; Oluyomi A Sowemimo; Philip J Cooper
Journal:  Nat Rev Dis Primers       Date:  2020-05-28       Impact factor: 52.329

4.  Allergen presensitization drives an eosinophil-dependent arrest in lung-specific helminth development.

Authors:  Pedro H Gazzinelli-Guimaraes; Rafael de Queiroz Prado; Alessandra Ricciardi; Sandra Bonne-Année; Joshua Sciurba; Erik P Karmele; Ricardo T Fujiwara; Thomas B Nutman
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

5.  Ascaris lumbricoides Cystatin Prevents Development of Allergic Airway Inflammation in a Mouse Model.

Authors:  Sandra Coronado; Josefina Zakzuk; Ronald Regino; Velky Ahumada; Ines Benedetti; Alba Angelina; Oscar Palomares; Luis Caraballo
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

Review 6.  Soil-Transmitted Helminth Vaccines: Are We Getting Closer?

Authors:  Ayat Zawawi; Kathryn J Else
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

7.  Identification and Physicochemical Characterization of a New Allergen from Ascaris lumbricoides.

Authors:  Velky Ahumada; María Manotas; Josefina Zakzuk; Lorenz Aglas; Sandra Coronado; Peter Briza; Peter Lackner; Ronald Regino; Galber Araujo; Fatima Ferreira; Luis Caraballo
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

8.  Foodborne Parasitic Diseases in the Neotropics - A Review.

Authors:  F Chávez-Ruvalcaba; M I Chávez-Ruvalcaba; K Moran Santibañez; J L Muñoz-Carrillo; A León Coria; R Reyna Martínez
Journal:  Helminthologia       Date:  2021-06-08       Impact factor: 1.184

9.  Classification of Wheezing Children in Rural Bangladesh by Intensity of Ascaris Infection, Total and Specific IgE Levels, History of Pneumonia, and Other Risk Factors.

Authors:  Haruko Takeuchi; Md Alfazal Khan; Khalequz Zaman; Sayaka Takanashi; S M Tafsir Hasan; Mohammad Yunus; Tsutomu Iwata
Journal:  J Immunol Res       Date:  2019-12-05       Impact factor: 4.818

Review 10.  Host Immunity and Inflammation to Pulmonary Helminth Infections.

Authors:  Jill E Weatherhead; Pedro Gazzinelli-Guimaraes; John M Knight; Ricardo Fujiwara; Peter J Hotez; Maria Elena Bottazzi; David B Corry
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.